Prop 2 vs HB 3001: Side-by-Side

Utah voters approved Proposition 2 on November 6, 2018. Five weeks earlier, legislative leaders and the LDS Church had already negotiated HB 3001 — the bill that would replace it. The substantive differences were sweeping: home grow eliminated, pharmacies replaced dispensaries, conditions narrowed, edibles reshaped into “gelatinous lozenges,” and supply capped.

Last verified: April 2026

The Two Proposals at a Glance

Proposition 2 was the citizen-drafted ballot initiative qualified by the Utah Patients Coalition in 2018. HB 3001 — the Utah Medical Cannabis Act — was the negotiated alternative that Gov. Gary Herbert signed on December 3, 2018, in a single-day special session. The two documents shared the goal of authorizing medical cannabis in Utah, but the architecture of access was completely rebuilt.

ElementProposition 2 (Nov 2018, 52.75%)HB 3001 (Dec 3, 2018, signed same day)
Home cultivation Up to 6 plants for any patient living more than 100 miles from a dispensary Eliminated entirely. No home grow under any condition
Retail outlets “Cannabis dispensaries” “Medical cannabis pharmacies” with required on-site licensed pharmacist (PMP)
Retail license cap Tied to population; effectively uncapped 7 private pharmacies + state “central fill” via county health departments (later abandoned)
Cultivation license cap No statutory cap on producers 10 maximum — 8 initially issued, still 8 today
Provider role Any licensed physician could recommend Physicians must register as Qualified Medical Providers (QMPs) — now Recommending Medical Providers (RMPs) — with continuing-education and patient-cap requirements
Qualifying conditions Broad list including PTSD, autoimmune disorders, chronic pain, “physical wasting” Narrowed: autoimmune disorders → HIV/AIDS specifically; “physical wasting” → cachexia
Edibles Brownies, gummies, cookies, conventional candies permitted All of those prohibited. Only cube-shaped or rectangular “gelatinous lozenges” allowed
Flower Permitted in standard packaging Only in sealed blister packs of 1 gram or less, for vaporization (not combustion)
Compassionate Use Not a separate process Compassionate Use Board created for non-listed conditions and minors

Home Cultivation: The Most Decisive Cut

The 100-mile home-grow provision in Prop 2 was the initiative’s most distinctive feature: a recognition that Utah’s rural geography would leave many patients without practical retail access. Garfield, Daggett, and Wayne counties have populations under 8,000; the nearest pharmacy could be a multi-hour drive. HB 3001 eliminated this provision entirely. The Compromise instead promised — through the “central fill” mechanism — that county health departments would dispense to rural patients, a concept that proved unworkable and was scrapped within nine months.

Pharmacies, Not Dispensaries

Renaming retail outlets “medical cannabis pharmacies” was not cosmetic. HB 3001 required each location to employ a Pharmacy Medical Provider (PMP) — a state-licensed pharmacist physically present during operating hours, supervising every transaction. This is the model Elder Jack N. Gerard described at the August 23, 2018 LDS press conference: “doctor-prescribed, in dosage form, through a licensed pharmacy.” The pharmacist-on-site requirement remains the structural backbone of Utah’s program eight years later.

The Church does not object to the medicinal use of marijuana, if doctor-prescribed, in dosage form, through a licensed pharmacy.

Elder Jack N. Gerard, August 23, 2018 — the formula codified in HB 3001

Form Factors Reshaped

The “gelatinous cube” rule on edibles is the most-cited oddity of HB 3001. Conventional dosage forms — brownies, gummies, hard candies, cookies — were prohibited on the explicit theory that they could be marketed to or mistaken for non-medical confections. Vaporization was permitted; combustion (smoking) was banned. Flower was allowed but only in sealed blister packs of one gram or less, an inhaler-pharmacy aesthetic intended to reinforce the pharmaceutical framing.

Conditions Narrowed

Prop 2’s broad qualifying-conditions list was tightened. “Autoimmune disorders” — potentially encompassing dozens of ICD-10 diagnoses — was replaced with HIV/AIDS specifically. “Physical wasting” was replaced with cachexia, a defined clinical syndrome. Persistent pain language was preserved. PTSD was retained. The Compassionate Use Board was created to handle non-listed conditions on a case-by-case basis, and to authorize cannabis for minors with parental consent.

What Has Loosened Since — and What Hasn’t

Eight years of amendments have softened HB 3001 on the margins: the central-fill concept was abandoned (SB 1002, 2019), the pharmacy cap rose from 7 to 17, flower may now ship in childproof bottles (SB 121, 2020), the LMP role lets ordinary controlled-substance prescribers recommend without QMP registration (SB 170, 2021). But the four pillars — no home grow, pharmacy model with on-site pharmacist, narrow form factors, capped supply chain — remain. See eight years later for the full ledger.

Explore More

Official Sources